EN
HI
Sun Pharmaceutical Industries share price chart
Sun Pharmaceutical Industries Share Key Metrics
Volume
54.14 L
Market Cap
473556.74 CR
LTQ@LTP
1@1973.70
ATP
1958.51
Var Margin
12.5 %
Circuit Range
1776.4-2171
Delivery %
83.07 %
Value
1060.41 CR
ASM/GSM
No
Market Lot
1
Summary
SUNPHARMA stock price is ₹1973.7 as of 28 Jul, 2026. The stock intraday movement has stayed between ₹1933.00 and ₹1977.00, while Sun Pharmaceutical Industries share price 52 week high low is ₹1548.00 & ₹1977.00.
In terms of trading activity, SUNPHARMA share price has recorded a volume of 54,14,380 shares. The Sun Pharmaceutical Industries has a market cap of ₹2399334970. The stock’s Average Traded Price (ATP) stands at ₹1958.51, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1973.70.
The Sun Pharmaceutical Industries upper circuit limit is ₹2171.00 & The Sun Pharmaceutical Industries lower circuit limit is ₹1776.40, with a Value of ₹1060.41 CR. The Delivery Percentage for the day is 83.07%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Sun Pharmaceutical Industries Fundamentals
P/E Ratio
40.57
P/B Ratio
5.57
Div. Yield
0.82
Sector P/E
63.39
Sector P/B
3.18
Sec. Div. Yield
0.53
Sun Pharmaceutical Industries Resistance and Support
Pivot 1961.23
Resistance
First Resistance
1989.46
Second Resistance
2005.23
Third Resistance
2033.46
Support
First Support
1945.46
Second Support
1917.23
Third Support
1901.46
Sun Pharmaceutical Industries Futures & Options
Sun Pharmaceutical Industries Option Chain
View Price, OI, Greeks & More...
28JUL26
1965.10
-0.90 (0.05%)
25AUG26
1979.40
-0.20 (0.01%)
29SEP26
1992.00
0.60 (0.03%)
SUNPHARMA|28JUL26 CE 1960.00
8.15
1.2 (17.27%)
SUNPHARMA|28JUL26 PE 1980.00
17.55
-0.5 (-2.77%)
Sun Pharmaceutical Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-01-31 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results & Interim Dividend |
| 2024-10-28 | Quarterly Results |
Sun Pharmaceutical Industries News
Sun Pharmaceutical Industries Ltd - 524715 - Update On Nidlegy
Sun Pharmaceutical's partner, Philogen, has resubmitted the Marketing Authorization Application (MAA) for Nidlegy™ to the European Medicines Agency (EMA). This updated submission is for the neoadjuvant treatment of locally advanced, fully resectable melanoma, and incorporates enhanced clinical data from the Phase III PIVOTAL study and addresses previous regulatory questions.
Jul 27 2026 16:00:08
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma announced that Organon shareholders have approved the proposed acquisition, where Organon will become a wholly-owned subsidiary of Sun Pharma Holdings USA, Inc. This approval is a significant milestone towards completing the transaction, which remains subject to customary closing conditions and regulatory approvals.
Jul 24 2026 08:50:33
Read More
Sun Pharmaceutical Industries Management
| Name | Position |
|---|---|
| Anoop Deshpande | Company Secretary & Compliance Officer |
| Dilip S Shanghvi | Chairman & Managing Director |
Sun Pharmaceutical Industries Similar Stocks
Divi's Laboratories Ltd.
7414.00
0.00 (0.00%)
Torrent Pharmaceuticals Ltd.
5019.50
0.00 (0.00%)
Apollo Hospitals Enterprise Ltd.
8843.50
0.00 (0.00%)
Cipla Ltd.
1409.40
0.00 (0.00%)
Zydus Lifesciences Ltd.
1108.20
0.00 (0.00%)
Lupin Ltd.
2410.00
0.00 (0.00%)
Max Healthcare Institute Ltd.
1114.60
0.00 (0.00%)
Mankind Pharma Ltd.
2551.60
0.00 (0.00%)
Lenskart Solutions Ltd.
572.00
0.00 (0.00%)
Dr. Reddy's Laboratories Ltd.
1150.80
0.00 (0.00%)
Sun Pharmaceutical Industries FAQs
The Buying Price of Sun Pharmaceutical Industries share is 1973.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sun Pharmaceutical Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sun Pharmaceutical Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sun Pharmaceutical Industries shares is 40.57. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sun Pharmaceutical Industries shares is 5.57. Useful to assess the stock's value relative to its book value.
To assess Sun Pharmaceutical Industries’s valuation compare Sector P/E, P/B which are 63.39 & 3.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sun Pharmaceutical Industries is 473556.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sun Pharmaceutical Industries share price is 1977.00 & 1548.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sun Pharmaceutical Industries belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
